Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recombinant”

2,727 trials

Showing 20 of 2,727 results

Early research (Phase 1)UnknownNCT04151407
What this trial is testing

The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 50
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Testing effectiveness (Phase 2)Study completedNCT00994929
What this trial is testing

Efficacy and Safety of IL-11 in DDAVP Unresponsive

Who this might be right for
Hemophilia AVon Willebrand Disease
University of Pittsburgh 9
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Large-scale testing (Phase 3)Looking for participantsNCT05761028
What this trial is testing

CM310 in Subjects With Moderate to Severe Asthma

Who this might be right for
Moderate to Severe Asthma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 600
Testing effectiveness (Phase 2)UnknownNCT00080977
What this trial is testing

High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Early research (Phase 1)Study completedNCT00002009
What this trial is testing

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Testing effectiveness (Phase 2)Study completedNCT03294798
What this trial is testing

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient

Who this might be right for
Hepatitis B Virus
Tianjin SinoBiotech Ltd. 11
Early research (Phase 1)Ended earlyNCT00415311
What this trial is testing

Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

Who this might be right for
Liver Transplantation
Enzon Pharmaceuticals, Inc. 24
Not applicableUnknownNCT04588844
What this trial is testing

Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.

Who this might be right for
Poor Ovarian Reserve
Shandong University 200
Not applicableUnknownNCT05070234
What this trial is testing

Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature

Who this might be right for
Small for Gestational Age InfantSilver-Russell SyndromeGenetic Diseases, Inborn
Chunxiu Gong 150
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Early research (Phase 1)Not Yet RecruitingNCT07484893
What this trial is testing

Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects

Who this might be right for
Healthy Adult Male
Shanghai Henlius Biotech 24
Large-scale testing (Phase 3)WithdrawnNCT01155752
What this trial is testing

Pulmozyme in Cystic Fibrosis With Sinusitis

Who this might be right for
SinusitisCystic Fibrosis
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT05016934
What this trial is testing

Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized

Who this might be right for
Covid19
Hospital do Coracao
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Not applicableStudy completedNCT00244114
What this trial is testing

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation